Mesenchymal stem cell-based therapy for ischemic stroke

Johnathon D. Anderson, Missy T. Pham, Zelenia Contreras, Madeline Hoon, Kyle D. Fink, Henrik J. Johansson, Julien Rossignol, Gary L. Dunbar, Megan Showalter, Oliver Fiehn, Charles S. Bramlett, Renee L. Bardini, Gerhard Bauer, Brian Fury, Kyle J. Hendrix, Frederic Chedin, Samir El-Andaloussi, Billianna Hwang, Michael S. Mulligan, Janne LehtiöJan A. Nolta

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available. Most currently approved treatments for ischemic stroke have narrow therapeutic windows, severely limiting the number of patients able to be treated. Mesenchymal stem cells represent a promising novel treatment for ischemic stroke. Numerous studies have demonstrated that mesenchymal stem cells functionally improve outcomes in rodent models of ischemic stroke. Recent studies have also shown that exosomes secreted by mesenchymal stem cells mediate much of this effect. In the present review, we summarize the current literature on the use of mesenchymal stem cells to treat ischemic stroke. Further studies investigating the mechanisms underlying mesenchymal stem cells tissue healing effects are warranted and would be of benefit to the field.

Original languageEnglish (US)
Article number36
JournalChinese Neurosurgical Journal
Volume2
Issue number1
DOIs
StatePublished - Nov 1 2016

Fingerprint

Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Stroke
Exosomes
Therapeutics
Rodentia
Incidence

Keywords

  • Exosomes
  • Ischemic stroke
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology
  • Neurology

Cite this

Mesenchymal stem cell-based therapy for ischemic stroke. / Anderson, Johnathon D.; Pham, Missy T.; Contreras, Zelenia; Hoon, Madeline; Fink, Kyle D.; Johansson, Henrik J.; Rossignol, Julien; Dunbar, Gary L.; Showalter, Megan; Fiehn, Oliver; Bramlett, Charles S.; Bardini, Renee L.; Bauer, Gerhard; Fury, Brian; Hendrix, Kyle J.; Chedin, Frederic; El-Andaloussi, Samir; Hwang, Billianna; Mulligan, Michael S.; Lehtiö, Janne; Nolta, Jan A.

In: Chinese Neurosurgical Journal, Vol. 2, No. 1, 36, 01.11.2016.

Research output: Contribution to journalReview article

Anderson, JD, Pham, MT, Contreras, Z, Hoon, M, Fink, KD, Johansson, HJ, Rossignol, J, Dunbar, GL, Showalter, M, Fiehn, O, Bramlett, CS, Bardini, RL, Bauer, G, Fury, B, Hendrix, KJ, Chedin, F, El-Andaloussi, S, Hwang, B, Mulligan, MS, Lehtiö, J & Nolta, JA 2016, 'Mesenchymal stem cell-based therapy for ischemic stroke', Chinese Neurosurgical Journal, vol. 2, no. 1, 36. https://doi.org/10.1186/s41016-016-0053-4
Anderson, Johnathon D. ; Pham, Missy T. ; Contreras, Zelenia ; Hoon, Madeline ; Fink, Kyle D. ; Johansson, Henrik J. ; Rossignol, Julien ; Dunbar, Gary L. ; Showalter, Megan ; Fiehn, Oliver ; Bramlett, Charles S. ; Bardini, Renee L. ; Bauer, Gerhard ; Fury, Brian ; Hendrix, Kyle J. ; Chedin, Frederic ; El-Andaloussi, Samir ; Hwang, Billianna ; Mulligan, Michael S. ; Lehtiö, Janne ; Nolta, Jan A. / Mesenchymal stem cell-based therapy for ischemic stroke. In: Chinese Neurosurgical Journal. 2016 ; Vol. 2, No. 1.
@article{6ae326ca3d974bcebe38c16fdd32500b,
title = "Mesenchymal stem cell-based therapy for ischemic stroke",
abstract = "Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available. Most currently approved treatments for ischemic stroke have narrow therapeutic windows, severely limiting the number of patients able to be treated. Mesenchymal stem cells represent a promising novel treatment for ischemic stroke. Numerous studies have demonstrated that mesenchymal stem cells functionally improve outcomes in rodent models of ischemic stroke. Recent studies have also shown that exosomes secreted by mesenchymal stem cells mediate much of this effect. In the present review, we summarize the current literature on the use of mesenchymal stem cells to treat ischemic stroke. Further studies investigating the mechanisms underlying mesenchymal stem cells tissue healing effects are warranted and would be of benefit to the field.",
keywords = "Exosomes, Ischemic stroke, Mesenchymal stem cells",
author = "Anderson, {Johnathon D.} and Pham, {Missy T.} and Zelenia Contreras and Madeline Hoon and Fink, {Kyle D.} and Johansson, {Henrik J.} and Julien Rossignol and Dunbar, {Gary L.} and Megan Showalter and Oliver Fiehn and Bramlett, {Charles S.} and Bardini, {Renee L.} and Gerhard Bauer and Brian Fury and Hendrix, {Kyle J.} and Frederic Chedin and Samir El-Andaloussi and Billianna Hwang and Mulligan, {Michael S.} and Janne Lehti{\"o} and Nolta, {Jan A.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1186/s41016-016-0053-4",
language = "English (US)",
volume = "2",
journal = "Chinese Neurosurgical Journal",
issn = "2057-4967",
number = "1",

}

TY - JOUR

T1 - Mesenchymal stem cell-based therapy for ischemic stroke

AU - Anderson, Johnathon D.

AU - Pham, Missy T.

AU - Contreras, Zelenia

AU - Hoon, Madeline

AU - Fink, Kyle D.

AU - Johansson, Henrik J.

AU - Rossignol, Julien

AU - Dunbar, Gary L.

AU - Showalter, Megan

AU - Fiehn, Oliver

AU - Bramlett, Charles S.

AU - Bardini, Renee L.

AU - Bauer, Gerhard

AU - Fury, Brian

AU - Hendrix, Kyle J.

AU - Chedin, Frederic

AU - El-Andaloussi, Samir

AU - Hwang, Billianna

AU - Mulligan, Michael S.

AU - Lehtiö, Janne

AU - Nolta, Jan A.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available. Most currently approved treatments for ischemic stroke have narrow therapeutic windows, severely limiting the number of patients able to be treated. Mesenchymal stem cells represent a promising novel treatment for ischemic stroke. Numerous studies have demonstrated that mesenchymal stem cells functionally improve outcomes in rodent models of ischemic stroke. Recent studies have also shown that exosomes secreted by mesenchymal stem cells mediate much of this effect. In the present review, we summarize the current literature on the use of mesenchymal stem cells to treat ischemic stroke. Further studies investigating the mechanisms underlying mesenchymal stem cells tissue healing effects are warranted and would be of benefit to the field.

AB - Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available. Most currently approved treatments for ischemic stroke have narrow therapeutic windows, severely limiting the number of patients able to be treated. Mesenchymal stem cells represent a promising novel treatment for ischemic stroke. Numerous studies have demonstrated that mesenchymal stem cells functionally improve outcomes in rodent models of ischemic stroke. Recent studies have also shown that exosomes secreted by mesenchymal stem cells mediate much of this effect. In the present review, we summarize the current literature on the use of mesenchymal stem cells to treat ischemic stroke. Further studies investigating the mechanisms underlying mesenchymal stem cells tissue healing effects are warranted and would be of benefit to the field.

KW - Exosomes

KW - Ischemic stroke

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=85025126675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025126675&partnerID=8YFLogxK

U2 - 10.1186/s41016-016-0053-4

DO - 10.1186/s41016-016-0053-4

M3 - Review article

AN - SCOPUS:85025126675

VL - 2

JO - Chinese Neurosurgical Journal

JF - Chinese Neurosurgical Journal

SN - 2057-4967

IS - 1

M1 - 36

ER -